Egyptian Journal of Cancer and Biomedical Research

The Egyptian Association for Cancer Research (EACR)

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Egyptian Journal of Cancer and Biomedical Research is an open-access journal published by The Egyptian Association for Cancer Research (EACR) in Egypt, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 115 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
The Egyptian Association for Cancer Research (EACR)
ISSN
3009-6391 · 3009-7312
Country
Egypt
Languages
english
Access
Open access
Declared publication charge
115 USD
Articles in DOAJ
284
Declared review time
10 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2026-05-14
Indexing
DOAJ
APC
115 USD
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

284

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

66

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy9
Added to DOAJ
2026-05-14
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Alternate titles
Egyptian Journal of Cancer and Biomedical Research (Online
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensScience: Biology (General)

LCC codes

RC254-282QH301-705.5

Subject areas

  • Liver Disease Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • Drug-Induced Hepatotoxicity and Protection
  • Drug-Induced Hepatotoxicity and Protection
  • Nigella sativa pharmacological applications
  • Cancer Research and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Immunotherapy and Immune Responses
Show all subjects (50)
  • Cancer Immunotherapy and Biomarkers
  • Radiopharmaceutical Chemistry and Applications
  • Advanced Radiotherapy Techniques
  • Cancer, Hypoxia, and Metabolism
  • Immunotherapy and Immune Responses
  • Cancer Research and Treatment
  • Nigella sativa pharmacological applications
  • Radiopharmaceutical Chemistry and Applications
  • Cancer Immunotherapy and Biomarkers
  • Advanced Radiotherapy Techniques
  • Head and Neck Cancer Studies
  • Hepatitis B Virus Studies
  • Gastric Cancer Management and Outcomes
  • Pomegranate: compositions and health benefits
  • Hepatitis C virus research
  • Pharmacological Effects of Natural Compounds
  • Bone Metabolism and Diseases
  • Breast Cancer Treatment Studies
  • Pomegranate: compositions and health benefits
  • Bone Metabolism and Diseases
  • Pharmacological Effects of Natural Compounds
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Natural Antidiabetic Agents Studies
  • Colorectal Cancer Treatments and Studies
  • Cell Adhesion Molecules Research
  • HER2/EGFR in Cancer Research
  • Gastric Cancer Management and Outcomes
  • Hepatitis B Virus Studies
  • Head and Neck Cancer Studies
  • Sarcoma Diagnosis and Treatment
  • Hepatitis C virus research
  • HER2/EGFR in Cancer Research
  • Cell Adhesion Molecules Research
  • Colorectal Cancer Treatments and Studies
  • Natural Antidiabetic Agents Studies
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cancer Treatment and Pharmacology
  • Advanced Breast Cancer Therapies
  • Sarcoma Diagnosis and Treatment

Keywords (DOAJ)

  • cancer and biomedical
  • biomedical research
  • cancer research
  • molecular biology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: